fda compounding semaglutide news today 2025 ๐จ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Hims & Hers stock falls
Description
The weight of evidence leans toward improvement in men with overweight or obesity
Telemedicine is not just about convenience its about compliance
Biophys Res
Studies of GLP-1 medications and real-world experience show that stopping treatment often leads to weight regain over time, he says
The takeaway from this analysis shouldnt be that people should avoid these drugs, says Pinto
